Market traders on Kalshi, a prediction platform, are pricing in a 73% probability that marijuana will be rescheduled to a lower drug category before 2027. This data point reflects shifting sentiment around U.S. drug policy reform and could signal broader regulatory shifts ahead. For those tracking policy-driven market movements and risk scenarios, such prediction market signals often precede actual legislative action. The timeline suggests significant momentum building around decriminalization efforts in the coming years.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
9 Likes
Reward
9
5
Repost
Share
Comment
0/400
BearEatsAll
· 4h ago
Wow, 73%? This prediction market is really betting on policy reform. It feels like the wave of marijuana legalization is really coming.
View OriginalReply0
MevHunter
· 4h ago
73% probability? Honestly, the prediction market feels even faster than the official actions this time, quite interesting.
View OriginalReply0
ForkLibertarian
· 4h ago
A 73% probability? Now the policy market is really speaking, and it feels like the legalization of marijuana is a done deal.
View OriginalReply0
MelonField
· 4h ago
73% probability, the prediction market is once again warming up policies in advance. I've seen this trick too many times.
View OriginalReply0
SmartMoneyWallet
· 4h ago
73% probability? To be honest, this number has a certain flavor to it. We need to see who is building this expectation behind the scenes... The big players are already positioning themselves early for policy dividends, while retail investors are still reading the news. The whales have already laid out their chips.
Market traders on Kalshi, a prediction platform, are pricing in a 73% probability that marijuana will be rescheduled to a lower drug category before 2027. This data point reflects shifting sentiment around U.S. drug policy reform and could signal broader regulatory shifts ahead. For those tracking policy-driven market movements and risk scenarios, such prediction market signals often precede actual legislative action. The timeline suggests significant momentum building around decriminalization efforts in the coming years.